(HealthDay)—A Chinese researcher has died after catching a rare infectious disease called the Monkey B virus, Chinese Center for Disease Control and Prevention officials say.
Jul 19, 2021
0
4
A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effective against SARS-COV-2 and promises to be ...
Jul 15, 2021
0
14
A group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate elicited ...
Jun 15, 2021
1
24
Yerkes National Primate Research Center researchers in collaboration with Institut Pasteur have determined a combination immunotherapy of Interleukin-21 (IL-21) and interferon alpha (IFNα) when added to antiviral therapy ...
May 17, 2021
0
62
When the world was coming to grips with an emerging global pandemic a year ago, scientists at Texas Biomedical Research Institute sprang into action. The rhesus macaques at the Southwest National Primate Research Center (SNPRC) ...
Apr 27, 2021
0
4
A team of scientists led by the Institute of Biomaterials and Bioengineering at Tokyo Medical and Dental University (TMDU) have created novel molecules that prevent human immunodeficiency virus (HIV) particles from attacking ...
Apr 15, 2021
0
4
In 1890, psychologist William James described attention as the spotlight we shine not only on the world around us, but also on the contents of our minds. Most cognitive scientists since then have drawn a sharp distinction ...
Mar 31, 2021
0
390
Animals must make predictions about future rewards when making decisions during daily life. Specific reward-related patterns of neuronal activity are known to underlie such decisions. But now, researchers from Japan have ...
Mar 19, 2021
0
0
Our knowledge of Alzheimer's disease has grown rapidly in the past few decades but it has proven difficult to translate fundamental discoveries about the disease into new treatments. Now researchers at the California National ...
Mar 18, 2021
0
7
A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected ...
Mar 1, 2021
0
28
